Genetics, deals, DNA

Illumina Allied with UK Sequencing Firm

Ryan McBride 1/12/09

Illumina (NASDAQ:ILMN), a San Diego-based provider of genetic and biological research tools, says it has formed an commercial alliance with Oxford Nanopore Technologies, an Oxford, England, developer of a single-molecule DNA sequencing system. Illumina will invest $18 million in Oxford as part of the deal, under which Illumina will exclusively sell and distribute Oxford’s experimental system worldwide.

Ryan McBride is Xconomy's correspondent. You can reach him at rmcbride@xconomy.com.